1. Home
  2. USEG vs APLT Comparison

USEG vs APLT Comparison

Compare USEG & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USEG
  • APLT
  • Stock Information
  • Founded
  • USEG 1966
  • APLT 2016
  • Country
  • USEG United States
  • APLT United States
  • Employees
  • USEG N/A
  • APLT N/A
  • Industry
  • USEG Oil & Gas Production
  • APLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • USEG Energy
  • APLT Health Care
  • Exchange
  • USEG Nasdaq
  • APLT Nasdaq
  • Market Cap
  • USEG 42.2M
  • APLT 44.0M
  • IPO Year
  • USEG N/A
  • APLT 2019
  • Fundamental
  • Price
  • USEG $1.36
  • APLT $0.41
  • Analyst Decision
  • USEG Strong Buy
  • APLT Buy
  • Analyst Count
  • USEG 1
  • APLT 7
  • Target Price
  • USEG $3.50
  • APLT $6.10
  • AVG Volume (30 Days)
  • USEG 9.5M
  • APLT 2.6M
  • Earning Date
  • USEG 08-06-2025
  • APLT 08-06-2025
  • Dividend Yield
  • USEG N/A
  • APLT N/A
  • EPS Growth
  • USEG N/A
  • APLT N/A
  • EPS
  • USEG N/A
  • APLT N/A
  • Revenue
  • USEG $16,340,000.00
  • APLT $265,000.00
  • Revenue This Year
  • USEG $23.82
  • APLT $1,768.13
  • Revenue Next Year
  • USEG N/A
  • APLT $292.85
  • P/E Ratio
  • USEG N/A
  • APLT N/A
  • Revenue Growth
  • USEG N/A
  • APLT N/A
  • 52 Week Low
  • USEG $0.81
  • APLT $0.30
  • 52 Week High
  • USEG $6.40
  • APLT $10.62
  • Technical
  • Relative Strength Index (RSI)
  • USEG 46.53
  • APLT 58.87
  • Support Level
  • USEG $1.30
  • APLT $0.32
  • Resistance Level
  • USEG $1.69
  • APLT $0.36
  • Average True Range (ATR)
  • USEG 0.14
  • APLT 0.04
  • MACD
  • USEG -0.04
  • APLT 0.01
  • Stochastic Oscillator
  • USEG 7.14
  • APLT 94.92

About USEG U.S. Energy Corp. (DE)

US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: